{
  "ticker": "AURA",
  "company_name": "AURA",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT06643884",
      "title": "Suprachoroidal Administration in Subjects With Metastases to the Choroid",
      "status": "RECRUITING",
      "phase": "PHASE2",
      "condition": "Eye Cancer, Primary Cancer",
      "start_date": "2024-12-16",
      "completion_date": "2027-10-31",
      "enrollment": 0,
      "sponsor": "Aura Biosciences"
    },
    {
      "nct_id": "NCT06664944",
      "title": "Technology Exposure and Child Health: Wellness Impact and Social Effects: an Observational Product Registry Study",
      "status": "RECRUITING",
      "phase": "",
      "condition": "Mood, Depression Disorders, Anxiety Disorders, Sleep, Eating Disorders, Physical Activity, Loneliness, Stress",
      "start_date": "2024-11-15",
      "completion_date": "2025-12",
      "enrollment": 0,
      "sponsor": "Aura"
    },
    {
      "nct_id": "NCT06007690",
      "title": "A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal Melanoma",
      "status": "RECRUITING",
      "phase": "PHASE3",
      "condition": "Choroidal Melanoma, Indeterminate Lesions, Uveal Melanoma, Ocular Melanoma",
      "start_date": "2023-12-06",
      "completion_date": "2028-08-15",
      "enrollment": 0,
      "sponsor": "Aura Biosciences"
    },
    {
      "nct_id": "NCT02860312",
      "title": "Long Term Physical Activity for Hemodialysis Patients",
      "status": "UNKNOWN",
      "phase": "NA",
      "condition": "End Stage Renal Disease on Hemodialysis",
      "start_date": "2016-09",
      "completion_date": "2019-05",
      "enrollment": 0,
      "sponsor": "AURA Sante"
    },
    {
      "nct_id": "NCT03350308",
      "title": "Prediction of Risk of Hypotension in Hemodialysis",
      "status": "COMPLETED",
      "phase": "",
      "condition": "Chronical Kidney Disease, Hypotension, Residual Blood Volume, Hemodialysis",
      "start_date": "2015-01-01",
      "completion_date": "2023-12-27",
      "enrollment": 0,
      "sponsor": "University Hospital, Clermont-Ferrand"
    },
    {
      "nct_id": "NCT05307601",
      "title": "Immune Response Following COVID-19 in Hemodialysis Patients",
      "status": "COMPLETED",
      "phase": "",
      "condition": "Dialysis; Complications, COVID-19, Cytokine Storm",
      "start_date": "2020-09-01",
      "completion_date": "2021-10-30",
      "enrollment": 0,
      "sponsor": "AURA Paris"
    },
    {
      "nct_id": "NCT05483868",
      "title": "A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer",
      "status": "RECRUITING",
      "phase": "PHASE1",
      "condition": "Non-muscle-invasive Bladder Cancer, Non-Muscle Invasive Bladder Cancer (&Amp;#34;NMIBC&Amp;#34;) Unresponsive/Intolerant to BCG, NMIBC, Non-Muscle Invasive Bladder Carcinoma, Non-Muscle Invasive Bladder Neoplasms, Non-Muscle Invasive Bladder Urothelial Carcinoma, Urothelial Carcinoma Bladder",
      "start_date": "2022-09-26",
      "completion_date": "2027-03",
      "enrollment": 0,
      "sponsor": "Aura Biosciences"
    },
    {
      "nct_id": "NCT04503772",
      "title": "Preoperative Stereotactic Radiosurgery for Brain Metastases",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Brain Metastases",
      "start_date": "2021-02-04",
      "completion_date": "2025-11-25",
      "enrollment": 0,
      "sponsor": "Centre Jean Perrin"
    },
    {
      "nct_id": "NCT04763811",
      "title": "Acceptability Study of Sensor in Elderly People's House Living Alone (Fragility Box)",
      "status": "COMPLETED",
      "phase": "",
      "condition": "Aging",
      "start_date": "2020-03-01",
      "completion_date": "2020-10-01",
      "enrollment": 0,
      "sponsor": "Centre Hospitalier Universitaire de Saint Etienne"
    },
    {
      "nct_id": "NCT05982145",
      "title": "The Use of Compression in Institutions and at People's Homes",
      "status": "COMPLETED",
      "phase": "",
      "condition": "Aging",
      "start_date": "2020-02-14",
      "completion_date": "2021-06-30",
      "enrollment": 0,
      "sponsor": "Centre Hospitalier Universitaire de Saint Etienne"
    }
  ],
  "summary": {
    "total_trials": 19,
    "by_phase": {
      "PHASE2": 3,
      "": 10,
      "PHASE3": 1,
      "NA": 3,
      "PHASE1": 1,
      "PHASE1, PHASE2": 1
    },
    "by_status": {
      "RECRUITING": 5,
      "UNKNOWN": 2,
      "COMPLETED": 11,
      "TERMINATED": 1
    },
    "active_trials": 5,
    "completed_trials": 11,
    "conditions": [
      "Aged, 80 and Over",
      "Aging",
      "Brain Metastases",
      "Choroidal Melanoma, Indeterminate Lesions",
      "Choroidal Melanoma, Indeterminate Lesions of Eye",
      "Choroidal Melanoma, Indeterminate Lesions, Uveal Melanoma, Ocular Melanoma",
      "Chronical Kidney Disease, Hypotension, Residual Blood Volume, Hemodialysis",
      "Dialysis; Complications, COVID-19, Cytokine Storm",
      "Disease",
      "End Stage Renal Disease on Hemodialysis",
      "Eye Cancer, Primary Cancer",
      "Hemodialysis Patients",
      "Mood, Depression Disorders, Anxiety Disorders, Sleep, Eating Disorders, Physical Activity, Loneliness, Stress",
      "Non-muscle-invasive Bladder Cancer, Non-Muscle Invasive Bladder Cancer (&Amp;#34;NMIBC&Amp;#34;) Unresponsive/Intolerant to BCG, NMIBC, Non-Muscle Invasive Bladder Carcinoma, Non-Muscle Invasive Bladder Neoplasms, Non-Muscle Invasive Bladder Urothelial Carcinoma, Urothelial Carcinoma Bladder",
      "Overweight, Postmenopausal Women",
      "Uveal Melanoma, Ocular Melanoma, Choroidal Melanoma"
    ],
    "lead_stage": "phase_3"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-12T09:45:45.930260",
    "search_query": "AURA",
    "url": "https://clinicaltrials.gov/search?term=AURA"
  }
}